Search

C26H38N2S4Sn, triclinic, P1‾ $P\overline{1}$ (no. 2), a = 9.6272(1) Å, b = 12.1043(2) Å, c = 13.3584(2) Å, α = 82.296(1)°, β = 86.611(1)°, γ = 66.912(1)°, V = 1419.02(4) Å3, Z = 2, Rgt (F) = 0.0235, wR ref(F 2) = 0.0612, T = 100 K.

Using the in situ method, the successful synthesis of dibutyltin(IV) N-methyl-N-benzyl dithiocarbamate (Compound 1) and tricyclohexyltin(IV) N-methyl-N-benzyl dithiocarbamate (Compound 2) was achieved. Both compounds were characterized by the CHNS elemental analysis, FTIR, NMR spectroscopies and X-ray crystallography study. The experimental CHNS values demonstrated good congruence with the CHNS's theoretical values of the suggested formula structures. The key infrared absorbance peaks, v(C-N) and v(C-S), which were found between 1475-1481 cm-1 and 971-975 cm-1, respectively. The 13C chemical shift of carbon in the NCS2 group was observed in the range of 200.66-202.32 ppm. The crystal structure of Compound 1 shows the anisobidentate's coordination mode between the central metal of the Sn atom and the dithiocarbamate ligands. Compound 1 and Compound 2 have shown great toxicity effects against carcinoma cells in the human lung (A549) with lower IC50 values of 0.80 µM and 2.77 µM, respectively. [ABSTRACT FROM AUTHOR]

C26H38N2S4Sn, triclinic, P 1 ‾ (no. 2), a = 9.6272(1) Å, b = 12.1043(2) Å, c = 13.3584(2) Å, α = 82.296(1)°, β = 86.611(1)°, γ = 66.912(1)°, V = 1419.02(4) Å3, Z = 2, Rgt(F) = 0.0235, wRref(F2) = 0.0612, T = 100 K. [ABSTRACT FROM AUTHOR]